Kevin Liaw

1.2k total citations
30 papers, 761 citations indexed

About

Kevin Liaw is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Kevin Liaw has authored 30 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Immunology and 7 papers in Oncology. Recurrent topics in Kevin Liaw's work include RNA Interference and Gene Delivery (9 papers), Dendrimers and Hyperbranched Polymers (7 papers) and CAR-T cell therapy research (6 papers). Kevin Liaw is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Dendrimers and Hyperbranched Polymers (7 papers) and CAR-T cell therapy research (6 papers). Kevin Liaw collaborates with scholars based in United States, Brazil and China. Kevin Liaw's co-authors include Sujatha Kannan, Rangaramanujam M. Kannan, Rishi Sharma, Anjali Sharma, Zhi Zhang, Michelle Chang, R.L. McDaniels, Fan Zhang, Barbara S. Slusher and Antonella Mangraviti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Kevin Liaw

29 papers receiving 757 citations

Peers

Kevin Liaw

BIOMA

NEURO

Zijian Yang United States

Jie Fan United States

Yun Mo China

Yachen Wang China

Cong Yan China

Xue Gou China

Shuihua Zhang China

Yazhou Wang China

Hongyan Long China

Jana Hedrich Germany

Zijian Yang United States

Kevin Liaw

735 ×2.3

349 ×2.2

32 ×0.2

BIOMA

79 ×0.6

64 ×0.6

NEURO

Citations per year, relative to Kevin Liaw Kevin Liaw (= 1×) peers Zijian Yang

Countries citing papers authored by Kevin Liaw

Since Specialization

Citations

This map shows the geographic impact of Kevin Liaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Liaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Liaw more than expected).

Fields of papers citing papers by Kevin Liaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Liaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Liaw. The network helps show where Kevin Liaw may publish in the future.

Co-authorship network of co-authors of Kevin Liaw

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Liaw. A scholar is included among the top collaborators of Kevin Liaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Liaw. Kevin Liaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Xizhou, Pratik Bhojnagarwala, Kevin Liaw, et al.. (2025). Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV. Frontiers in Immunology. 16. 1535261–1535261.

O’Connell, Ryan P., Kevin Liaw, Nils Wellhausen, et al.. (2024). Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 12(6). e008733–e008733. 6 indexed citations

Park, Daniel H., Pratik Bhojnagarwala, Kevin Liaw, et al.. (2024). Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells. Journal for ImmunoTherapy of Cancer. 12(12). e009604–e009604. 4 indexed citations

Park, Daniel H., Kevin Liaw, Pratik Bhojnagarwala, et al.. (2023). Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape. Molecular Therapy — Oncolytics. 28. 249–263. 11 indexed citations

Tursi, Nicholas J., Ziyang Xu, Susanne N. Walker, et al.. (2023). Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo. Frontiers in Immunology. 14. 1072810–1072810. 3 indexed citations

Bordoloi, Devivasha, Pratik Bhojnagarwala, Alfredo Perales‐Puchalt, et al.. (2022). A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy. JCI Insight. 7(22). 14 indexed citations

Tallon, Carolyn, Anjali Sharma, Zhi Zhang, et al.. (2022). Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics. 19(1). 274–288. 15 indexed citations

Bhojnagarwala, Pratik, Ryan P. O’Connell, Daniel Park, et al.. (2022). In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme. Molecular Therapy — Oncolytics. 26. 289–301. 12 indexed citations

Harris, Michael A., Huihui Kuang, Zachary Schneiderman, et al.. (2021). ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survival. Science Advances. 7(49). eabl5872–eabl5872. 19 indexed citations

10.

Zhu, Xizhou, Alfredo Perales‐Puchalt, Ziyang Xu, et al.. (2021). DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas. Molecular Therapy — Oncolytics. 24. 218–229. 5 indexed citations

11.

Sharma, Rishi, Kevin Liaw, Anjali Sharma, et al.. (2021). Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma. Journal of Controlled Release. 337. 179–192. 76 indexed citations

12.

Hollinger, Kristen R., Anjali Sharma, Carolyn Tallon, et al.. (2021). Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis. Nanotheranostics. 6(2). 126–142. 26 indexed citations

13.

Liaw, Kevin, et al.. (2020). Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma. Journal of Controlled Release. 329. 434–444. 36 indexed citations

14.

Liaw, Kevin, Fan Zhang, Antonella Mangraviti, et al.. (2020). Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration. Bioengineering & Translational Medicine. 5(2). e10160–e10160. 52 indexed citations

15.

Liaw, Kevin, Rajasekhar R. Ramireddy, Anjali Sharma, et al.. (2020). Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma. Bioengineering & Translational Medicine. 6(2). e10205–e10205. 30 indexed citations

16.

Sharma, Anjali, Kevin Liaw, Rishi Sharma, et al.. (2018). Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics. Theranostics. 8(20). 5529–5547. 128 indexed citations

17.

Liaw, Kevin, et al.. (2018). Quantitative assessment of surface functionality effects on microglial uptake and retention of PAMAM dendrimers. Journal of Nanoparticle Research. 20(4). 19 indexed citations

18.

Niederhauser, Blake D., et al.. (2013). Pick Up a Book or “Google It?” A Survey of Radiologist and Trainee-Preferred References and Resources. Journal of Digital Imaging. 27(1). 26–32. 11 indexed citations

19.

Spottswood, Stephanie E., Kevin Liaw, Marta Hernanz‐Schulman, et al.. (2009). The clinical impact of the radiology report in wheezing and nonwheezing febrile children: a survey of clinicians. Pediatric Radiology. 39(4). 348–353. 12 indexed citations

20.

Liaw, Kevin & J. Herman Kan. (2008). Lipofibromatous hamartoma. Pediatric Radiology. 38(9). 1032–1032. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact